Acute Porphyria Drug Database

A06AD65 - Macrogol, Combinations
Not porphyrinogenic
NP

Rationale
Macrogols are not absorbed from the gastrointestinal tract.
Chemical description
Mixtures of polymers.
Therapeutic characteristics
Macrogols are used as osmotic laxatives. A mixture of macrogol 3350 or 4000 with electrolytes is used for bowel preparation before colonoscopy, radiological procedures, or surgery. Common adverse reactions of macrogols that can be confused with an acute porphyric attack are gastrointestinal discomfort, bloating, and nausea.
Metabolism and pharmakokinetics
Not absorbed from the garstrointerstinal tract, eliminated in feces.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

References

  1. Drug reference publications
  2. Sweetman SC, editor. Martindale: The complete drug reference. Macrogols. Pharmaceutical Press 2009. #1091
  3. Summary of Product Characteristics
  4. Norwegian medicines agency. Summary of Product Characteristics (SPC). Laxabon. #1094

Similar drugs
Explore alternative drugs in similar therapeutic classes A06A / A06AD or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙